JP2015512948A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015512948A5 JP2015512948A5 JP2015505961A JP2015505961A JP2015512948A5 JP 2015512948 A5 JP2015512948 A5 JP 2015512948A5 JP 2015505961 A JP2015505961 A JP 2015505961A JP 2015505961 A JP2015505961 A JP 2015505961A JP 2015512948 A5 JP2015512948 A5 JP 2015512948A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- compound
- colchicine
- composition according
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- IAKHMKGGTNLKSZ-INIZCTEOSA-N Colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 claims 20
- 150000001875 compounds Chemical class 0.000 claims 11
- 239000008194 pharmaceutical composition Substances 0.000 claims 11
- 229960001338 colchicine Drugs 0.000 claims 10
- 201000005569 gout Diseases 0.000 claims 9
- 206010015150 Erythema Diseases 0.000 claims 7
- 239000002253 acid Substances 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000011780 sodium chloride Substances 0.000 claims 4
- 230000000875 corresponding Effects 0.000 claims 2
- 201000001431 hyperuricemia Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000008203 oral pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261624186P | 2012-04-13 | 2012-04-13 | |
| US61/624,186 | 2012-04-13 | ||
| PCT/US2013/036474 WO2013155478A1 (en) | 2012-04-13 | 2013-04-12 | Method for treating hyperuricemia in patients with gout using halofenate or halofenic acid and an anti-inflammatory agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015512948A JP2015512948A (ja) | 2015-04-30 |
| JP2015512948A5 true JP2015512948A5 (US07981874-20110719-C00313.png) | 2016-06-02 |
Family
ID=49325641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015505961A Pending JP2015512948A (ja) | 2012-04-13 | 2013-04-12 | ハロフェナートまたはハロフェン酸および抗炎症剤を用いる痛風に罹っている患者の高尿酸血症の治療方法 |
Country Status (15)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2914255T3 (pl) | 2012-11-02 | 2022-01-03 | Murray & Poole Enterprises, Ltd. | Leczenie incydentów sercowo-naczyniowych lub zapobieganie im poprzez podawanie kolchicyny |
| CA2909370A1 (en) | 2013-04-16 | 2014-10-23 | Murray And Poole Enterprises Limited | Sustained-release formulations of colchicine and methods of using same |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6262118B1 (en) * | 1999-06-04 | 2001-07-17 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
| US7576131B2 (en) * | 1999-06-04 | 2009-08-18 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| EP3517109A1 (en) * | 2008-03-13 | 2019-07-31 | Wellstat Therapeutics Corporation | Compounds and method for reducing uric acid |
| CN102123595A (zh) * | 2008-03-14 | 2011-07-13 | 因特里赫伯有限责任公司 | 抑制龋齿形成的甘草棒棒糖 |
| US20100137235A1 (en) * | 2008-10-15 | 2010-06-03 | Mutual Pharmaceutical Company, Inc. | Methods for Concomitant Administration of Colchicine and Macrolide Antibiotics |
| CN109908124A (zh) * | 2011-11-04 | 2019-06-21 | 西玛贝医药公司 | 利用卤芬酯或卤芬酸以及第二尿酸降低剂治疗痛风患者中高尿酸血症的方法 |
| JP6008974B2 (ja) * | 2011-11-04 | 2016-10-19 | サイマベイ・セラピューティクス・インコーポレイテッドＣｙｍａＢａｙ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | 痛風発赤の治療方法 |
| JP6047172B2 (ja) * | 2011-11-04 | 2016-12-21 | サイマベイ・セラピューティクス・インコーポレイテッドＣｙｍａＢａｙ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | 患者部分集団における痛風の治療方法 |
-
2013
- 2013-04-12 AU AU2013245675A patent/AU2013245675B2/en not_active Ceased
- 2013-04-12 CA CA2870014A patent/CA2870014A1/en not_active Abandoned
- 2013-04-12 WO PCT/US2013/036474 patent/WO2013155478A1/en active Application Filing
- 2013-04-12 SG SG11201406495UA patent/SG11201406495UA/en unknown
- 2013-04-12 US US13/862,262 patent/US20130274331A1/en not_active Abandoned
- 2013-04-12 EP EP13776027.8A patent/EP2836209A4/en not_active Withdrawn
- 2013-04-12 EA EA201491870A patent/EA028495B1/ru not_active IP Right Cessation
- 2013-04-12 JP JP2015505961A patent/JP2015512948A/ja active Pending
- 2013-04-12 KR KR20147031687A patent/KR20150002799A/ko unknown
- 2013-04-12 MX MX2014012376A patent/MX2014012376A/es unknown
- 2013-04-12 CN CN201380030570.9A patent/CN104602686A/zh active Pending
-
2014
- 2014-10-10 PH PH12014502282A patent/PH12014502282A1/en unknown
- 2014-10-10 CL CL2014002728A patent/CL2014002728A1/es unknown
- 2014-10-19 IL IL235154A patent/IL235154A0/en unknown
-
2015
- 2015-04-15 HK HK15103663.3A patent/HK1204913A1/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012193216A5 (US07981874-20110719-C00313.png) | ||
| JP2012255026A5 (US07981874-20110719-C00313.png) | ||
| JP2013525444A5 (US07981874-20110719-C00313.png) | ||
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| JP2014507446A5 (US07981874-20110719-C00313.png) | ||
| PH12015502628B1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of disease | |
| JP2016518337A5 (US07981874-20110719-C00313.png) | ||
| CL2014002935A1 (es) | Metodo para tratar un paciente humano con esclerosis multiple con laquinimod, en una dosis diaria de alrededor de 1,2mg; un aforma de dosificacion unitaria oral de 1,2 mg de laquinimod y un portador | |
| MX2015016344A (es) | Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades. | |
| PE20142353A1 (es) | Ansolvatos de sal de noribogaina | |
| JP2014526503A5 (US07981874-20110719-C00313.png) | ||
| JP2015155440A5 (US07981874-20110719-C00313.png) | ||
| JP2015533163A5 (US07981874-20110719-C00313.png) | ||
| JP2013522326A5 (US07981874-20110719-C00313.png) | ||
| JP2013541583A5 (US07981874-20110719-C00313.png) | ||
| JP2015516419A5 (US07981874-20110719-C00313.png) | ||
| FI2683245T4 (fi) | Menetelmiä ja koostumuksia masennuksen hoitamiseen syklobentsapriiniä käyttämällä | |
| RU2019110980A (ru) | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением | |
| JP2016515550A5 (US07981874-20110719-C00313.png) | ||
| RU2013157398A (ru) | Композиция | |
| JP2015512948A5 (US07981874-20110719-C00313.png) | ||
| JP2014518280A5 (US07981874-20110719-C00313.png) | ||
| GR1008228B (el) | Φαρμακευτικο σκευασμα περιεχον ενα διπλο αναστολεα επαναπροσληψης και μεθοδος για την παρασκευη αυτου | |
| EA201390844A1 (ru) | Комплексный состав, содержащий гидрохлорид лерканидипина и валсартан, и способ его получения | |
| JP2012041314A5 (US07981874-20110719-C00313.png) |
